These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

947 related articles for article (PubMed ID: 2882014)

  • 1. CPP, a selective N-methyl-D-aspartate (NMDA)-type receptor antagonist: characterization in vitro and in vivo.
    Lehmann J; Schneider J; McPherson S; Murphy DE; Bernard P; Tsai C; Bennett DA; Pastor G; Steel DJ; Boehm C
    J Pharmacol Exp Ther; 1987 Mar; 240(3):737-46. PubMed ID: 2882014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CGS 19755, a selective and competitive N-methyl-D-aspartate-type excitatory amino acid receptor antagonist.
    Lehmann J; Hutchison AJ; McPherson SE; Mondadori C; Schmutz M; Sinton CM; Tsai C; Murphy DE; Steel DJ; Williams M
    J Pharmacol Exp Ther; 1988 Jul; 246(1):65-75. PubMed ID: 2899170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. II. Evidence for N-methyl-D-aspartate receptor antagonist properties.
    Carter C; Benavides J; Legendre P; Vincent JD; Noel F; Thuret F; Lloyd KG; Arbilla S; Zivkovic B; MacKenzie ET
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1222-32. PubMed ID: 2849669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Action of 3-((+/-)-2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid (CPP): a new and highly potent antagonist of N-methyl-D-aspartate receptors in the hippocampus.
    Harris EW; Ganong AH; Monaghan DT; Watkins JC; Cotman CW
    Brain Res; 1986 Sep; 382(1):174-7. PubMed ID: 2876750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guanine nucleotides are competitive inhibitors of N-methyl-D-aspartate at its receptor site both in vitro and in vivo.
    Baron BM; Dudley MW; McCarty DR; Miller FP; Reynolds IJ; Schmidt CJ
    J Pharmacol Exp Ther; 1989 Jul; 250(1):162-9. PubMed ID: 2545857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the inhibition of excitatory amino acid-induced neurotransmitter release in the rat striatum by phencyclidine-like drugs.
    Snell LD; Johnson KM
    J Pharmacol Exp Ther; 1986 Sep; 238(3):938-46. PubMed ID: 2875174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of [3H]3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid to rat brain membranes: a selective, high-affinity ligand for N-methyl-D-aspartate receptors.
    Murphy DE; Schneider J; Boehm C; Lehmann J; Williams M
    J Pharmacol Exp Ther; 1987 Mar; 240(3):778-84. PubMed ID: 3031274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CGP 37849 and CGP 39551: novel and potent competitive N-methyl-D-aspartate receptor antagonists with oral activity.
    Fagg GE; Olpe HR; Pozza MF; Baud J; Steinmann M; Schmutz M; Portet C; Baumann P; Thedinga K; Bittiger H
    Br J Pharmacol; 1990 Apr; 99(4):791-7. PubMed ID: 1972895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localization of N-methyl-D-aspartate receptors in the rat striatum: effects of specific lesions on the [3H]3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid binding.
    Samuel D; Errami M; Nieoullon A
    J Neurochem; 1990 Jun; 54(6):1926-33. PubMed ID: 2159977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homocysteic acid as a putative excitatory amino acid neurotransmitter: I. Postsynaptic characteristics at N-methyl-D-aspartate-type receptors on striatal cholinergic interneurons.
    Lehmann J; Tsai C; Wood PL
    J Neurochem; 1988 Dec; 51(6):1765-70. PubMed ID: 2846784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two classes of N-methyl-D-aspartate recognition sites: differential distribution and differential regulation by glycine.
    Monaghan DT; Olverman HJ; Nguyen L; Watkins JC; Cotman CW
    Proc Natl Acad Sci U S A; 1988 Dec; 85(24):9836-40. PubMed ID: 2904680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscle relaxant and anticonvulsant activity of 3-((+/-)-2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid, a novel N-methyl-D-aspartate antagonist, in rodents.
    Turski L; Klockgether T; Sontag KH; Herrling PL; Watkins JC
    Neurosci Lett; 1987 Jan; 73(2):143-8. PubMed ID: 3029636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enantiomers of HA-966 (3-amino-1-hydroxypyrrolid-2-one) exhibit distinct central nervous system effects: (+)-HA-966 is a selective glycine/N-methyl-D-aspartate receptor antagonist, but (-)-HA-966 is a potent gamma-butyrolactone-like sedative.
    Singh L; Donald AE; Foster AC; Hutson PH; Iversen LL; Iversen SD; Kemp JA; Leeson PD; Marshall GR; Oles RJ
    Proc Natl Acad Sci U S A; 1990 Jan; 87(1):347-51. PubMed ID: 2153294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonism of N-methyl-D-aspartate (NMDA) evoked increases in cerebellar cGMP and striatal ACh release by phencyclidine (PCP) receptor agonists: evidence for possible allosteric coupling of NMDA and PCP receptors.
    Wood PL; Steel D; McPherson SE; Cheney DL; Lehmann J
    Can J Physiol Pharmacol; 1987 Sep; 65(9):1923-7. PubMed ID: 2825947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological profile of NPC 12626, a novel, competitive N-methyl-D-aspartate receptor antagonist.
    Ferkany JW; Kyle DJ; Willets J; Rzeszotarski WJ; Guzewska ME; Ellenberger SR; Jones SM; Sacaan AI; Snell LD; Borosky S
    J Pharmacol Exp Ther; 1989 Jul; 250(1):100-9. PubMed ID: 2545856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurochemical interactions of competitive N-methyl-D-aspartate antagonists with dopaminergic neurotransmission and the cerebellar cyclic GMP system: functional evidence for a phasic glutamatergic control of the nigrostriatal dopaminergic pathway.
    Rao TS; Cler JA; Mick SJ; Emmett MR; Farah JM; Contreras PC; Iyengar S; Wood PL
    J Neurochem; 1991 Mar; 56(3):907-13. PubMed ID: 1847188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The novel anticonvulsant MK-801 binds to the activated state of the N-methyl-D-aspartate receptor in rat brain.
    Foster AC; Wong EH
    Br J Pharmacol; 1987 Jun; 91(2):403-9. PubMed ID: 2886170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the binding of [3H]-CGS 19755: a novel N-methyl-D-aspartate antagonist with nanomolar affinity in rat brain.
    Murphy DE; Hutchison AJ; Hurt SD; Williams M; Sills MA
    Br J Pharmacol; 1988 Nov; 95(3):932-8. PubMed ID: 2850065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vinpocetine preferentially antagonizes quisqualate/AMPA receptor responses: evidence from release and ligand binding studies.
    Kiss B; Cai NS; Erdö SL
    Eur J Pharmacol; 1991 Dec; 209(1-2):109-12. PubMed ID: 1687679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CGS 19755 is a potent and competitive antagonist at NMDA-type receptors.
    Lehmann J; Chapman AG; Meldrum BS; Hutchison A; Tsai C; Wood PL
    Eur J Pharmacol; 1988 Sep; 154(1):89-93. PubMed ID: 2846329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.